These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38236528)

  • 41. Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells.
    Poto R; Patella V; Criscuolo G; Marone G; Coscioni E; Varricchi G
    Clin Exp Med; 2023 Aug; 23(4):1265-1276. PubMed ID: 35879625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life study.
    Buttgereit T; Gu S; Carneiro-Leão L; Gutsche A; Maurer M; Siebenhaar F
    Allergy; 2022 Sep; 77(9):2794-2802. PubMed ID: 35364617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis.
    Granerus G; Lönnqvist B; Roupe G
    Agents Actions; 1994 Jun; 41 Spec No():C127-8. PubMed ID: 7526641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells.
    Veien M; Szlam F; Holden JT; Yamaguchi K; Denson DD; Levy JH
    Anesthesiology; 2000 Apr; 92(4):1074-81. PubMed ID: 10754628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a tryptase depletion index for better pathologic identification of mast cell activation syndrome.
    Zienkiewicz T; Homann J; Mücke M; Seidel H; Hertfelder HJ; Weinstock LB; Afrin LB; Molderings GJ
    Z Gastroenterol; 2023 Mar; 61(3):268-274. PubMed ID: 35576976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.
    Hamilton MJ
    Curr Gastroenterol Rep; 2024 Apr; 26(4):107-114. PubMed ID: 38353900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis.
    van Toorenenbergen AW; Oranje AP
    Clin Chim Acta; 2005 Sep; 359(1-2):72-7. PubMed ID: 15913591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mast cell activation in arthritis: detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid.
    Buckley MG; Walters C; Wong WM; Cawley MI; Ren S; Schwartz LB; Walls AF
    Clin Sci (Lond); 1997 Oct; 93(4):363-70. PubMed ID: 9404229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
    Shin H; Lyons JJ
    Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization.
    de Paulis A; Marinò I; Ciccarelli A; de Crescenzo G; Concardi M; Verga L; Arbustini E; Marone G
    Arthritis Rheum; 1996 Jul; 39(7):1222-33. PubMed ID: 8670335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mast cell activation in children with migraine before and after training in self-regulation.
    Olness K; Hall H; Rozniecki JJ; Schmidt W; Theoharides TC
    Headache; 1999 Feb; 39(2):101-7. PubMed ID: 15613202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
    Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
    J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mast cell effector mechanisms.
    Lane SJ; Lee TH
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 2):S67-71; discussion S71-2. PubMed ID: 8939179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A sensitive colorimetric assay for the release of tryptase from human lung mast cells in vitro.
    Lavens SE; Proud D; Warner JA
    J Immunol Methods; 1993 Nov; 166(1):93-102. PubMed ID: 7693824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome.
    Giannetti MP; Akin C; Castells M
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1196-1201. PubMed ID: 32276688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase.
    He S; Gaça MD; Walls AF
    J Pharmacol Exp Ther; 1998 Jul; 286(1):289-97. PubMed ID: 9655871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
    Sladek K; Szczeklik A
    Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mast Cell Activation Disorders.
    Giannetti A; Filice E; Caffarelli C; Ricci G; Pession A
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33573161
    [No Abstract]   [Full Text] [Related]  

  • 59. Markers of mast cell degranulation.
    Hogan AD; Schwartz LB
    Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The differentiation and function of myofibroblasts is regulated by mast cell mediators.
    Gailit J; Marchese MJ; Kew RR; Gruber BL
    J Invest Dermatol; 2001 Nov; 117(5):1113-9. PubMed ID: 11710921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.